NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.
Frequently asked questions
What sector does NRXBF (NRXBF) operate in?
NRXBF belongs to the Healthcare sector and operates in the Biotechnology industry.
What is NRXBF (NRXBF) current stock price?
As of the latest data, NRXBF stock price is $0.36, with a previous close of $0.41. NRXBF lost -$0.05 in the last trading session, representing a -12.93% loss.
What is NRXBF (NRXBF) current market capitalization?
NRXBF market cap is approximately 32.86 million.
What is NRXBF (NRXBF) Earnings Per Share (EPS)?
The trailing EPS is -$0.08.
What is NRXBF (NRXBF) EBITDA?
NRXBF EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.61 million.
Does NRXBF (NRXBF) pay dividends?
No. NRXBF does not pay a dividend.
What is NRXBF (NRXBF) beta (volatility) score?
NRXBF has a beta of 0.331, indicating lower volatility than the overall market.